Accendra Health, Inc. Common Stock (ACH)
Industrials › Wholesale-Medical, Dental & Hospital Equipment & Supplies
Price History
Feb 9, 2026 — Apr 4, 2026Investment Snapshot
- Piotroski F-Score 6/9 — moderate financial health
- ROE of 23.6% — good return on equity
- Revenue declining 74% annually
Accendra Health, Inc. Common Stock (ACH) is a Industrials company operating in Wholesale-Medical, Dental & Hospital Equipment & Supplies, listed on the NYSE , with a market capitalisation of $182 million . Key value metrics: Piotroski F-Score 6 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Accendra Health, Inc. Common Stock — Fundamental Analysis Summary
On financial health, ACH shows a moderate Piotroski F-Score of 6/9, and strong return on equity of 23.6% (sector average: 5.5%), and elevated leverage with a debt-to-equity ratio of 1.01.
StockPik's composite Value Score for ACH is 57/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ACH reports a moderate gross margin of 33.0% (sector average: 24.7%) and a modest operating margin of 0.2%.
ACH shows revenue declining at 74% year-over-year, with earnings declining at 203%.